Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VetFamily Højbjerg Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.4% 3.0% 4.7% 6.3% 6.3% 5.9% 19.7% 19.7%   Credit score (0-100)   55 57 44 37 36 39 6 6   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,885 4,238 4,899 6,177 7,653 8,632 0.0 0.0   EBITDA   1,103 1,206 1,886 2,766 3,625 3,692 0.0 0.0   EBIT   813 808 1,525 2,446 3,357 3,514 0.0 0.0   Pre-tax profit (PTP)   908.5 931.2 1,510.6 4,211.0 3,358.8 3,519.0 0.0 0.0   Net earnings   728.3 754.8 1,174.5 3,674.7 2,619.7 2,743.9 0.0 0.0   Pre-tax profit without non-rec. items   908 931 1,511 4,211 3,359 3,519 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,562 1,206 845 361 307 208 0.0 0.0   Shareholders equity total   1,530 1,785 2,359 2,513 2,933 3,177 232 232   Interest-bearing liabilities   800 800 0.0 28.8 23.1 28.7 0.0 0.0   Balance sheet total (assets)   3,515 4,506 3,961 4,046 5,039 5,009 232 232   Net Debt   110 -883 -1,886 -2,707 -3,626 -3,645 -232 -232     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,885 4,238 4,899 6,177 7,653 8,632 0.0 0.0   Gross profit growth   -0.1% 9.1% 15.6% 26.1% 23.9% 12.8% -100.0% 0.0%   Employees   6 6 6 7 8 10 0 0   Employee growth %   0.0% 0.0% 0.0% 16.7% 14.3% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,515 4,506 3,961 4,046 5,039 5,009 232 232   Balance sheet change%   31.7% 28.2% -12.1% 2.1% 24.5% -0.6% -95.4% 0.0%   Added value   1,103.1 1,206.3 1,886.2 2,766.3 3,677.3 3,692.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   600 -753 -723 -804 -322 -278 -208 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.9% 19.1% 31.1% 39.6% 43.9% 40.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.3% 24.4% 36.5% 105.8% 73.9% 70.1% 0.0% 0.0%   ROI %   49.6% 38.0% 60.4% 172.9% 122.2% 114.3% 0.0% 0.0%   ROE %   49.7% 45.5% 56.7% 150.8% 96.2% 89.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   43.5% 39.6% 59.6% 62.1% 58.2% 63.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   10.0% -73.2% -100.0% -97.9% -100.0% -98.7% 0.0% 0.0%   Gearing %   52.3% 44.8% 0.0% 1.1% 0.8% 0.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.4% 6.0% 8.7% 182.4% -1.2% 8.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.3 1.6 1.6 2.0 1.9 2.2 0.0 0.0   Current Ratio   1.6 1.8 1.9 2.3 2.2 2.5 0.0 0.0   Cash and cash equivalent   689.9 1,683.2 1,886.4 2,736.0 3,649.4 3,673.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   692.5 1,425.3 1,384.4 1,957.9 2,431.7 2,774.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   184 201 314 395 460 369 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   184 201 314 395 453 369 0 0   EBIT / employee   136 135 254 349 420 351 0 0   Net earnings / employee   121 126 196 525 327 274 0 0